Skip to main content
Equibles

JONES FINANCIAL COMPANIES LLLP

Position in VTGN — Vistagen Therapeutics, Inc.

CIK 815917 DES PERES, MO
Back to VTGN Full portfolio

Position in VTGN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$26
-$38 QoQ
Shares Held
114
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#45
of 48 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in VTGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JONES FINANCIAL COMPANIES LLLP holds $339,983,928 across 287 Biotechnology names. VTGN ranks #276 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 215,419 $107,005,079
2 TECH
BIO-TECHNE Corp
 797,001 $56,308,120
3 SLS
SELLAS Life Sciences Group, Inc.
 2,304,561 $34,015,320
4 ALNY
Alnylam Pharmaceuticals, Inc.
 80,491 $24,230,204
5 REGN
Regeneron Pharmaceuticals, Inc.
 28,691 $17,889,985
6 ARGX
Argenx SE
 14,657 $13,598,324
7 ARDX
Ardelyx, Inc.
 1,765,932 $9,006,253
8 INSM
INSMED Inc
 68,803 $7,335,774

All Filings in VTGN

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $26 114
2026-03-31 $64 114
2025-12-31 $75 114
2025-09-30 $404 114
2025-06-30 $228 114
2025-03-31 $200 80
2024-12-31 $826 280
2024-09-30 $240 80
2024-06-30 $278 80
2024-03-31 $422 80
2023-12-31 $411 80